As the COVID-19 pandemic continues, the virus responsible, SARS-CoV-2, continues to spread and mutate, resulting in the emergence of novel variants that could have important consequences in the fight against this virus. Some variants may spread more easily, while others could cause more serious disease. In order to keep up with this virus and continue our fight against it, it is critical that we identify and track both known and novel SARS-CoV-2 variants.
The best and least biased method for variant identification and tracking is SARS-CoV-2 whole genome sequencing. While this method is optimal for variant identification and tracking, whole genome Next Generation Sequencing is complicated and requires both extensive expertise, resources and instrumentation.
To help alleviate the strain on current Next Generation Sequencing laboratories and provide access to sequencing resources that many researchers may not have, LGC, Biosearch Technologies offers SARS-CoV-2 whole genome sequencing and variant identification service. For Research Use Only. Not for use in diagnostic procedures. This service is currently available to customers in Europe, the Middle East and Africa.